Jesus Beltran is an inventor and biotechnology entrepreneur dedicated to making biology programmable. As the scientific co-founder and Chief Scientific Officer of DNAmic Biosystems, he leads the development of human-derived cellular reprogramming platforms designed to teach new therapeutic functions to living cells directly within the body.

Dr. Beltran is the lead inventor behind DNAmic's core technology platform and has dedicated his career to building technologies that transform biology from something we observe into something we can instruct. His work focuses on developing programmable biological systems capable of teaching cells entirely new therapeutic functions, transforming them into active agents of repair, regeneration, and disease elimination. These efforts have generated multiple patented technologies, scientific publications in leading international journals, and have laid the foundation for thousands of subsequent studies conducted by researchers and institutions worldwide.

Prior to co-founding DNAmic, Dr. Beltran built an international scientific career across Europe and the United States, conducting research in Spain, Norway, Switzerland, and California. His work has focused on the intersection of cellular engineering, synthetic biology, regenerative medicine, and next-generation therapeutics, with the goal of creating technologies capable of fundamentally changing how diseases are treated.
‍
At DNAmic, he is responsible for scientific strategy, platform innovation, and translational development. His long-term vision is to make biology programmable, enabling cells to learn new therapeutic functions and transforming medicine from treating disease to instructing cells to restore health.